NO20064359L - Stabil farmasoytisk losningsformulering fror trykksatt doseringsinhalator - Google Patents

Stabil farmasoytisk losningsformulering fror trykksatt doseringsinhalator

Info

Publication number
NO20064359L
NO20064359L NO20064359A NO20064359A NO20064359L NO 20064359 L NO20064359 L NO 20064359L NO 20064359 A NO20064359 A NO 20064359A NO 20064359 A NO20064359 A NO 20064359A NO 20064359 L NO20064359 L NO 20064359L
Authority
NO
Norway
Prior art keywords
solution formulation
stable pharmaceutical
pharmaceutical solution
hydroxy
pressurized dosage
Prior art date
Application number
NO20064359A
Other languages
English (en)
Inventor
Maurizio Delcanale
David Lewis
David Ganderton
Brian John Meakin
Fausto Pivetti
Original Assignee
Chiesi Farma Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from EP04011424A external-priority patent/EP1595531A1/en
Application filed by Chiesi Farma Spa filed Critical Chiesi Farma Spa
Publication of NO20064359L publication Critical patent/NO20064359L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/12—Aerosols; Foams
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4704—2-Quinolinones, e.g. carbostyril
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B65—CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
    • B65D—CONTAINERS FOR STORAGE OR TRANSPORT OF ARTICLES OR MATERIALS, e.g. BAGS, BARRELS, BOTTLES, BOXES, CANS, CARTONS, CRATES, DRUMS, JARS, TANKS, HOPPERS, FORWARDING CONTAINERS; ACCESSORIES, CLOSURES, OR FITTINGS THEREFOR; PACKAGING ELEMENTS; PACKAGES
    • B65D83/00—Containers or packages with special means for dispensing contents
    • B65D83/14—Containers or packages with special means for dispensing contents for delivery of liquid or semi-liquid contents by internal gaseous pressure, i.e. aerosol containers comprising propellant for a product delivered by a propellant
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00—Inhalators
    • A61M15/009—Inhalators using medicine packages with incorporated spraying means, e.g. aerosol cans

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Dispersion Chemistry (AREA)
  • Otolaryngology (AREA)
  • Inorganic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Mechanical Engineering (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Aerosolløsningsformuleringer for anvendelse i en aerosolinhalator, omfattende 8-hydroksy-5[(lR)-l- hydroksy-2-[[(lR)-2-(4-metoksyfenyl)l-metyletyl]amino]etyl]-2(lH)-kinolinon eller et salt av dette, spesielt hydrogenkloridsaltet (TA 2005), som en aktiv ingrediens, et drivmiddel som inneholder et hydrogenfiuoralkan og et koløsningsmiddel, stabilisert ved å tilsette en bestemt liten mengde høykonsentrert fosforsyre, og eventuelt anvende en egnet boks hvor en del av, eller hele, den innvendige metalloverfiate er belagt med et inert organisk belegg.
NO20064359A 2004-02-27 2006-09-26 Stabil farmasoytisk losningsformulering fror trykksatt doseringsinhalator NO20064359L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US54779804P 2004-02-27 2004-02-27
EP04011424A EP1595531A1 (en) 2004-05-13 2004-05-13 Stable pharmaceutical solution formulations for pressurized metered dose inhalers
PCT/EP2005/002042 WO2005084640A1 (en) 2004-02-27 2005-02-25 Stable pharmaceutical solution formulations for pressurized metered dose inhalers

Publications (1)

Publication Number Publication Date
NO20064359L true NO20064359L (no) 2006-09-26

Family

ID=34921308

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20064359A NO20064359L (no) 2004-02-27 2006-09-26 Stabil farmasoytisk losningsformulering fror trykksatt doseringsinhalator

Country Status (6)

Country Link
US (1) US20070025920A1 (no)
KR (1) KR20070000476A (no)
HK (1) HK1103280A1 (no)
IL (1) IL177103A0 (no)
MA (1) MA28485B1 (no)
NO (1) NO20064359L (no)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005112902A2 (en) * 2004-05-13 2005-12-01 Chiesi Farmaceutici S.P.A. Medicinal aerosol formulation products with improved chemical stability
US8227027B2 (en) * 2007-12-07 2012-07-24 Presspart Gmbh & Co. Kg Method for applying a polymer coating to an internal surface of a container
US8532271B2 (en) * 2009-01-21 2013-09-10 Chung-Yu Lin Cybercrime detecting and preventing method and system established by telephone number code, authorization codes and source identification code

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8334494D0 (en) * 1983-12-24 1984-02-01 Tanabe Seiyaku Co Carbostyril derivatives
AU6048694A (en) * 1992-12-09 1994-07-04 Paul D. Jager Stabilized medicinal aerosol solution formulations
CN1217654C (zh) * 1995-04-14 2005-09-07 史密丝克莱恩比彻姆公司 舒喘宁的计定剂量吸入器
CN1113675C (zh) * 1995-04-14 2003-07-09 葛兰素惠尔康公司 丙酸福地卡松的计定剂量吸入器
DE59911149D1 (de) * 1998-07-24 2004-12-30 Jago Res Ag Muttenz Medizinische aerosolformulierungen
DE19847969A1 (de) * 1998-10-17 2000-04-20 Boehringer Ingelheim Pharma Lagerfähig flüssige Formulierung mit Formoterol
DZ2947A1 (fr) * 1998-11-25 2004-03-15 Chiesi Farma Spa Inhalateur à compteur de dose sous pression.
IT1303788B1 (it) * 1998-11-25 2001-02-23 Chiesi Farma Spa Formulazioni di aerosol medicinali.
AU2000250701B2 (en) * 2000-05-22 2004-07-01 Chiesi Farmaceutici S.P.A. Stable pharmaceutical solution formulations for pressurised metered dose inhalers
EP1340492A1 (en) * 2002-03-01 2003-09-03 CHIESI FARMACEUTICI S.p.A. Aerosol formulations for pulmonary administration of medicaments having systemic effects
DK3494995T3 (da) * 2002-03-01 2020-03-23 Chiesi Farm Spa Superfin formoterolformulering
EP1595531A1 (en) * 2004-05-13 2005-11-16 CHIESI FARMACEUTICI S.p.A. Stable pharmaceutical solution formulations for pressurized metered dose inhalers

Also Published As

Publication number Publication date
KR20070000476A (ko) 2007-01-02
HK1103280A1 (en) 2007-12-14
IL177103A0 (en) 2006-12-10
US20070025920A1 (en) 2007-02-01
MA28485B1 (fr) 2007-03-01

Similar Documents

Publication Publication Date Title
EA200601578A1 (ru) Стабильные фармацевтические растворы для дозированных ингаляторов под давлением
US7893050B2 (en) Fasudil in combination therapies for the treatment of pulmonary arterial hypertension
WO2007095043A3 (en) Pharmaceutical formulations
WO2007014673A3 (en) Pharmaceutical formulations comprising a long-acting beta2-agonist for administration by nebulisation
CA2492976A1 (en) Solution for ungual and peri-ungual application
GEP20063876B (en) Pressurised metered dose inhalers containing solutions of beta-2 agonists
DK2840080T3 (da) Nitrogenholdig heterocyklisk forbindelse eller salt deraf
US20150258047A1 (en) Therapeutic Compounds
NO20080220L (no) Formuleringer med hoy medikament belastning og doseringsformer
NO20064359L (no) Stabil farmasoytisk losningsformulering fror trykksatt doseringsinhalator
SG183006A1 (en) Pharmaceutical composition for topical application of poorly soluble compounds
MX2021012487A (es) Compuestos derivados de pirazolopirazina, composicion farmaceutica y uso de la misma.
CA2488422A1 (en) Stable solid medicinal ramosetron composition for oral administration
AR054230A1 (es) Formulaciones farmaceuticas en aerosol para inhaladores de cartucho presurizados que comprenden un agente secuestrante
SI1771180T1 (sl) Zmes v obliki prsila, ki vsebuje kombinacijo klobetazol propionata in kalcitrola, alkoholna faza inoljna faza
UA88894C2 (ru) Стабильные фармацевтические композиции в виде растворов для ингаляторов с дозатором, которые находятся под давлением
US20130274650A1 (en) Stabilized ketorolac compositions
BRPI0417011A (pt) composições compreendendo compostos orgánicos
JO2709B1 (ar) تركيبات لمحاليل طبية ثابتة للاستخدام في أجهزة استنشاق تعطي جرعات مقاسة مضغوطة
EP2351569B1 (en) Fasudil in combination therapies for the treatment of pulmonary arterial hypertension
BR112012027000A2 (pt) fármaco para tuberculose a base de perclorato de 4-tioureído-iminometilpiridínio: método de preparação e tratamento
US8697712B2 (en) Presentation of an antiviral pharmaceutical composition
KR102538216B9 (ko) 폴리감마글루탐산을 유효성분으로 포함하는 코로나바이러스(SARS-CoV-2) 감염질환의 예방, 경감 또는 치료용 약학적 조성물
AR122989A1 (es) Formulación farmacéutica tópica estable que contiene un inmunosupresor para el tratamiento de afecciones dermatológicas
MX2023013474A (es) Formulaciones de suspension acuosa orales que comprenden compuesto de carbamato.

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application